Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 177

1.

Patterns of beta-blocker intensification in ambulatory heart failure patients and short-term association with hospitalization.

Allen LA, Magid DJ, Zeng C, Peterson PN, Clarke CL, Shetterly S, Brand DW, Masoudi FA.

BMC Cardiovasc Disord. 2012 Jun 18;12:43. doi: 10.1186/1471-2261-12-43.

2.

Optimization of heart FailUre medical Treatment after hospital discharge according to left ventricUlaR Ejection fraction: the FUTURE survey.

Cohen Solal A, Leurs I, Assyag P, Beauvais F, Clerson P, Contre C, Thebaut JF, Genoun M; French National College of Cardiologists.

Arch Cardiovasc Dis. 2012 Jun-Jul;105(6-7):355-65. doi: 10.1016/j.acvd.2012.04.003. Epub 2012 Jun 28.

3.

National use and effectiveness of beta-blockers for the treatment of elderly patients after acute myocardial infarction: National Cooperative Cardiovascular Project.

Krumholz HM, Radford MJ, Wang Y, Chen J, Heiat A, Marciniak TA.

JAMA. 1998 Aug 19;280(7):623-9. Erratum in: JAMA 1999 Jan 6;281(1):37.

PMID:
9718054
5.

Dosing of beta-blocker therapy before, during, and after hospitalization for heart failure (from Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure).

Fonarow GC, Abraham WT, Albert NM, Stough WG, Gheorghiade M, Greenberg BH, O'Connor CM, Sun JL, Yancy CW, Young JB.

Am J Cardiol. 2008 Dec 1;102(11):1524-9. doi: 10.1016/j.amjcard.2008.07.045. Epub 2008 Sep 6.

PMID:
19026308
6.

Optimization of pharmacotherapy in chronic heart failure: is heart rate adequately addressed?

Franke J, Wolter JS, Meme L, Keppler J, Tschierschke R, Katus HA, Zugck C.

Clin Res Cardiol. 2013 Jan;102(1):23-31. doi: 10.1007/s00392-012-0489-2. Epub 2012 Jul 4.

PMID:
22760479
7.

Carvedilol use at discharge in patients hospitalized for heart failure is associated with improved survival: an analysis from Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF).

Fonarow GC, Abraham WT, Albert NM, Stough WG, Gheorghiade M, Greenberg BH, O'Connor CM, Sun JL, Yancy C, Young JB; OPTIMIZE-HF Investigators and Coordinators.

Am Heart J. 2007 Jan;153(1):82.e1-11.

PMID:
17174643
8.

Beta-blocker Use and 30-day All-cause Readmission in Medicare Beneficiaries with Systolic Heart Failure.

Bhatia V, Bajaj NS, Sanam K, Hashim T, Morgan CJ, Prabhu SD, Fonarow GC, Deedwania P, Butler J, Carson P, Love TE, Kheirbek R, Aronow WS, Anker SD, Waagstein F, Fletcher R, Allman RM, Ahmed A.

Am J Med. 2015 Jul;128(7):715-21. doi: 10.1016/j.amjmed.2014.11.036. Epub 2014 Dec 30.

PMID:
25554369
9.

Uptitration of renin-angiotensin system blocker and beta-blocker therapy in patients hospitalized for heart failure with reduced versus preserved left ventricular ejection fractions.

Verbrugge FH, Duchenne J, Bertrand PB, Dupont M, Tang WH, Mullens W.

Am J Cardiol. 2013 Dec 15;112(12):1913-20. doi: 10.1016/j.amjcard.2013.08.013.

PMID:
24286620
10.

Predictors of mortality after discharge in patients hospitalized with heart failure: an analysis from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF).

O'Connor CM, Abraham WT, Albert NM, Clare R, Gattis Stough W, Gheorghiade M, Greenberg BH, Yancy CW, Young JB, Fonarow GC.

Am Heart J. 2008 Oct;156(4):662-73. doi: 10.1016/j.ahj.2008.04.030.

PMID:
18926148
11.

Influence of beta-blocker continuation or withdrawal on outcomes in patients hospitalized with heart failure: findings from the OPTIMIZE-HF program.

Fonarow GC, Abraham WT, Albert NM, Stough WG, Gheorghiade M, Greenberg BH, O'Connor CM, Sun JL, Yancy CW, Young JB; OPTIMIZE-HF Investigators and Coordinators.

J Am Coll Cardiol. 2008 Jul 15;52(3):190-9. doi: 10.1016/j.jacc.2008.03.048.

12.

A regional quality improvement effort to increase beta blocker administration before vascular surgery.

Goodney PP, Eldrup-Jorgensen J, Nolan BW, Bertges DJ, Likosky DS, Cronenwett JL; Vascular Study Group of New England.

J Vasc Surg. 2011 May;53(5):1316-1328.e1; discussion 1327-8. doi: 10.1016/j.jvs.2010.10.131. Epub 2011 Feb 21.

13.

Impact of acute beta-blocker therapy for patients with non-ST-segment elevation myocardial infarction.

Miller CD, Roe MT, Mulgund J, Hoekstra JW, Santos R, Pollack CV Jr, Ohman EM, Gibler WB, Peterson ED.

Am J Med. 2007 Aug;120(8):685-92.

PMID:
17679127
14.

Pre-discharge initiation of beta-blocker therapy in elderly patients hospitalized for acute decompensation of chronic heart failure: an effective strategy for the implementation of beta-blockade in heart failure.

Tarantini L, Cioffi G, Opasich C, Di Lenarda A, Pulignano G, Del Sindaco D, De Feo S, Stefenelli C, Russo P, Catania G.

Ital Heart J. 2004 Jun;5(6):441-9.

PMID:
15320569
15.

Comparative effectiveness of beta-adrenergic antagonists (atenolol, metoprolol tartrate, carvedilol) on the risk of rehospitalization in adults with heart failure.

Go AS, Yang J, Gurwitz JH, Hsu J, Lane K, Platt R.

Am J Cardiol. 2007 Aug 15;100(4):690-6. Epub 2007 Jun 26.

PMID:
17697830
16.

Comparison of late mortality in hospitalized patients >70 years of age with systolic heart failure receiving beta blockers versus those not receiving beta blockers.

Pascual-Figal DA, Redondo B, Caro C, Manzano S, Garrido IP, Ruipérez JA, Valdés M.

Am J Cardiol. 2008 Dec 15;102(12):1711-7. doi: 10.1016/j.amjcard.2008.07.059. Epub 2008 Sep 20.

PMID:
19064029
17.

Outpatient management of heart failure in the United States, 2006-2008.

Mosalpuria K, Agarwal SK, Yaemsiri S, Pierre-Louis B, Saba S, Alvarez R, Russell SD.

Tex Heart Inst J. 2014 Jun 1;41(3):253-61. doi: 10.14503/THIJ-12-2947. eCollection 2014 Jun.

18.

Effect of beta-blocker use on outcomes after discharge in patients who underwent cardiac surgery.

Chan AY, McAlister FA, Norris CM, Johnstone D, Bakal JA, Ross DB; Alberta Provincial Program for Outcome Assessment in Coronary Heart Disease (APPROACH) Investigators.

J Thorac Cardiovasc Surg. 2010 Jul;140(1):182-7, 187.e1. doi: 10.1016/j.jtcvs.2010.03.015. Epub 2010 Apr 28.

19.
20.

First hospitalization for heart failure in France in 2009: patient characteristics and 30-day follow-up.

Tuppin P, Cuerq A, de Peretti C, Fagot-Campagna A, Danchin N, Juillière Y, Alla F, Allemand H, Bauters C, Drici MD, Hagège A, Jondeau G, Jourdain P, Leizorovicz A, Paccaud F.

Arch Cardiovasc Dis. 2013 Nov;106(11):570-85. doi: 10.1016/j.acvd.2013.08.002. Epub 2013 Oct 18.

Items per page

Supplemental Content

Write to the Help Desk